Hypoparathyroidism Clinical Trial
Official title:
Comparison of the Prognostic Value of Perioperative Parathormone Measurement and Sodium Bicarbonate Infusion Test in the Evaluation of Parathyroid Function After Total Thyroidectomy
Verified date | October 2009 |
Source | Aristotle University Of Thessaloniki |
Contact | n/a |
Is FDA regulated | No |
Health authority | Greece: Ethics Committee |
Study type | Observational |
In the study will be included patients that have undergone total thyroidectomy and do not display obvious clinical or laboratory hypoparathyroidism. On the third postoperative day and before the patient's exit from the hospital, the patient will undergo an intravenous infusion test with 35ml/m2 dilution of 8.4%(w/v) sodium bicarbonate in two minutes. Three months after the operation, if the study conditions are still met, the patient will undergo an additional parathyroid hormone (PTH) measurement and sodium bicarbonate infusion test and the parathyroid function will be evaluated again.
Status | Completed |
Enrollment | 127 |
Est. completion date | October 2009 |
Est. primary completion date | September 2009 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years and older |
Eligibility |
Inclusion criteria for the patient group 1. Patient is over 18 years old 2. Patient scheduled for total thyroidectomy 3. Patient signs and dates a written informed consent form (ICF) and indicates an understanding of the study procedures Exclusion criteria the patient group: 1. Primary hyperparathyroidism 2. Primary hypoparathyroidism 3. Diabetes mellitus 4. Chronic Renal Failure 5. Hypoalbuminemia 6. Systematic Diseases (e.g., infections, neoplasmas) 7. Thyroid or parathyroid cancer 8. Osteoporosis 9. Drugs that influence calcium metabolism (vitamin D analogues, oral calcium supplements, biphosphonates, teriparatide, thiazide diuretics) 10. Osteomalacia 11. Neck irradiation Inclusion criteria for the control group 1. Participant is over 18 years old 2. Participant signs and dates a written informed consent form (ICF) and indicates an understanding of the study procedures Exclusion criteria of the control group: 1. All the above mentioned, in addition to prior thyroid surgery. |
Observational Model: Cohort, Time Perspective: Prospective
Country | Name | City | State |
---|---|---|---|
Greece | AHEPA University Hospital | Thessaloniki |
Lead Sponsor | Collaborator |
---|---|
Aristotle University Of Thessaloniki | AHEPA University Hospital |
Greece,
Iwasaki Y, Mutsuga N, Yamamori E, Kakita A, Oiso Y, Imai T, Funahashi H, Tanaka Y, Kondo K, Nakashima N. Sodium bicarbonate infusion test: a new method for evaluating parathyroid function. Endocr J. 2003 Oct;50(5):545-51. — View Citation
Warren FM, Andersen PE, Wax MK, Cohen JI. Perioperative parathyroid hormone levels in thyroid surgery: preliminary report. Laryngoscope. 2004 Apr;114(4):689-93. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Compare the prognostic value in the evaluation of parathyroid function of perioperative PTH measurement and sodium bicarbonate infusion test after total thyroidectomy | 3 months | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT03364738 -
Safety and Efficacy Study of rhPTH(1-84) in Subjects With Hypoparathyroidism
|
Phase 3 | |
Active, not recruiting |
NCT00856401 -
ADD-ON Study to Existing Hypoparathyroidism Studies
|
Phase 3 | |
Completed |
NCT05043584 -
Near-infrared Autofluorescence (NIRAF)-Guided Total Thyroidectomy: Impact in Low-volume, Non-parathyroid Institutions
|
N/A | |
Completed |
NCT03728959 -
Effects of a Liquid Meal and Gut Hormones (GIP and GLP-2) on Bone Remodeling in Participants With Hypoparathyroidism.
|
N/A | |
Not yet recruiting |
NCT06445036 -
Tunisian Clinical Registry on Hypoparathyroidism and Pseudo-hypoparathyroidism.
|
||
Recruiting |
NCT05556629 -
A Survey to Assess Participants' and Physicians' Knowledge, Attitudes and Behavior When Using NATPARA
|
||
Terminated |
NCT00395538 -
Effects of PTH Replacement on Bone in Hypoparathyroidism
|
Phase 3 | |
Completed |
NCT02910466 -
A Study of Extended Use of Recombinant Human Parathyroid Hormone (rhPTH(1-84)) in Hypoparathyroidism
|
Phase 4 | |
Completed |
NCT00001304 -
Treatment of Hypoparathyroidism With Synthetic Human Parathyroid Hormone 1-34
|
Phase 2 | |
Completed |
NCT04569604 -
QoL and Cognitive Function in Patients With Hypoparathyroidism
|
||
Completed |
NCT06449729 -
Endocrine Determinants of Renal Function in Patients With Hypoparathyroidism
|
||
Completed |
NCT03747029 -
Serum Calcium to Phosphorous (Ca/P) Ratio in the Diagnosis of Ca-P Metabolism Disorders: a Multicentre Study
|
||
Completed |
NCT05684029 -
Near-Infrared Autofluorescence With PTH Test Strip as an SOP of Parathyroid in Thyroid Surgery
|
||
Not yet recruiting |
NCT06419270 -
Cardiovascular, Renal, and Skeletal Complications in Patients With Post-Surgical Hypoparathyroidism
|
||
Completed |
NCT00473265 -
Bone Properties in Hypoparathyroidism: Effects of PTH
|
Phase 2/Phase 3 | |
Active, not recruiting |
NCT05328076 -
Parathyroid Vascularization During Total Thyroidectomy Using Indocyanine Green Angiography
|
||
Completed |
NCT03150108 -
Study of rhPTH(1-84) in Japanese Healthy Subjects Compared With Matched Caucasian Healthy Adult Subjects
|
Phase 1 | |
Completed |
NCT04059380 -
Evaluation of iMmune Function in Post-surgical and AuToimmune HYpoparathyroidism (EMPATHY)
|
||
Active, not recruiting |
NCT05965167 -
Assess Safety and Compare PK of New Oral hPTH(1-34) Tablet Formulations vs. EBP05 Tablets and Subcutaneous Forteo
|
Phase 1/Phase 2 | |
Recruiting |
NCT02986607 -
Corticosteroid Rhythms in Hypoparathyroid Patients
|
Early Phase 1 |